Regulations

172 texts found

• Note to establishments 18 Note No. 18 to all technical director pharmacists of pharmaceutical manufacturing and operating establishments in the East and West regions Full text
• Note to establishments 19 Note No. 19 on the admissibility review of files submitted for the registration of generic medicines Full text
• Note to establishments 23 Note No. 23 on electronic commerce Full text
• Note to establishments 24 Reminder Note No. 24 on the filing of regularisation files Full text
• Note to establishments 28 Reminder Note No. 28 on the filing of regularisation applications Full text
• Note to establishments Note to pharmaceutical manufacturing and operating establishments Full text
• Note to establishments 34 Note No. 34 on the procedures for reviewing pre-submission applications for pharmaceutical products subject to registration Full text
• Note to establishments 35 Final Reminder Note No. 35 on the filing of regularisation applications Full text
• Note to establishments 36 Note No. 36 on the change of the National Agency for Pharmaceutical Products bank details dedicated to the fee Full text
• Note to establishments 38-2025 Note No. 38-2025 on the declaration template for imported non-approved medical devices Full text
• Note to establishments 37-2025 Note No. 37-2025 on imported non-approved medical devices Full text
• Note to establishments 39-2025 Note No. 39-2025 on lifting reservations on files submitted for medical device approval (22-09-2025) Full text
• Note to establishments 40-2025 Note No. 40-2025 on the filing of approval files for marketed non-approved medical devices (22-09-2025) Full text
• Note to establishments 41-2025 Note No. 41-2025 on the launch of the E-TASJIL V2 platform Full text
• Note to establishments 45-2025 Note No. 45-2025 on the guidelines for bioequivalence studies Full text